Free Trial
→ Nobody Understands Why Trump Is Invading Iran (here’s the answer) (From Banyan Hill Publishing) (Ad)tc pixel
NASDAQ:HCMA

HCM Acquisition 5/14/2026 Earnings Report

HCM Acquisition logo
$10.14 -0.01 (-0.05%)
Closing price 05/15/2026 01:34 PM Eastern
Extended Trading
$10.14 0.00 (-0.04%)
As of 05/15/2026 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

HCM Acquisition EPS Results

Actual EPS
$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

HCM Acquisition Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

HCM Acquisition Announcement Details

Quarter
Date
5/14/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

HCM Acquisition Earnings Headlines

HCM III Acquisition Corp Class A HCMA
May 14 at 5:12 PM  |  morningstar.comM
Hcm III Acquisition Corp.
April 13, 2026  |  fool.comhttps://www.fool.com/quote/nasdaq/hcma/
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
May 17 at 1:00 AM  |  Brownstone Research (Ad)
HCM IV Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 6, 2026
April 2, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/hcm-iv-acquisition-corp-announces-the-separate-trading-of-its-class-a-ordinary-shares-and-warrants-commencing-april-6-2026-1035991072
HCMA HCM III Acquisition Corp.
February 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/HCMA
Imbria Pharmaceuticals Partners with Hypertrophic Cardiomyopathy Association to Support FORTITUDE-HCM Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy
October 16, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/imbria-pharmaceuticals-partners-with-hypertrophic-cardiomyopathy-association-to-support-fortitude-hcm-trial-evaluating-ninerafaxstat-for-non-obstructive-hypertrophic-cardiomyopathy-1035384472
See More HCM Acquisition Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HCM Acquisition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HCM Acquisition and other key companies, straight to your email.

About HCM Acquisition

HCM Acquisition (NASDAQ:HCMA). is a Delaware‐incorporated special purpose acquisition company (SPAC) that was formed to identify and complete a business combination with one or more target businesses. The company raised capital through its initial public offering and is listed on the Nasdaq under the ticker HCMA. As a blank check vehicle, HCM Acquisition holds its funds in trust until it consummates a qualifying merger, share exchange, asset acquisition or other business combination.

The SPAC is sponsored by affiliates of Healthcare Capital Management LLC, a Los Angeles‐based investment firm with experience in healthcare and life sciences investing. While HCM Acquisition maintains the flexibility to pursue opportunities across a range of sectors—including healthcare, consumer and retail, technology and media—its sponsor’s background provides specialized insight into healthcare and related industries. The management team leverages this expertise, along with an extensive network of industry contacts, to evaluate potential targets and structure transactions aimed at delivering long‐term value for shareholders.

Under the terms of its charter, HCM Acquisition must complete a business combination within the prescribed period, typically 18 to 24 months from its IPO. If no suitable transaction is finalized within this timeframe, the company will liquidate its trust and return funds to public shareholders. At this time, HCM Acquisition continues to explore potential merger candidates and has not yet announced a definitive agreement for a business combination.

View HCM Acquisition Profile
Earnings Tools